A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease

Clinical trial NCT04030962 · COMPLETED

Trial details

NCT number: NCT04030962
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Dry Eye Disease Dry Eye Syndrome

Start date: 2020-03-04
Primary completion: 2022-03-18
Enrollment: 292

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.